MET and non-small cell lung carcinoma: A polyethylene glycol (PEG)–modified crizotinib derivative (18F-FPC, Figure 5) was synthesized by Cheng et al. and evaluated in c-MET-positive (H1399 cell) and negative (A549 cell) NSCLC rodent models (192).